Tata India Pharma & HealthCare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Tata India Pharma & HealthCare Fund Growth Fund Overview

Min. investment

SIP ₹100 & Lump. ₹5000

AUM (Fund size)

₹1,541 Cr

Lock In Period

N/A

Expense Ratio

2.28

Exit Load

0.25% of NAV if redeemed/switched out before 30 days from the date of allotment.

Benchmark

BSE Healthcare Total Return

Tata India Pharma & HealthCare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M1.130.425.34
6M13.482.7626.10
1Y8.125.4624.61
3Y18.7214.6693.28

Portfolio Analysis

  • Equity: 99.13%
  • Debt: 0.87%
  • Others
As on: 2026-07-31
View allocation % by

1. SUN PHARMACEUTICAL INDUSTRIES LTD8.59%
2. DIVI LABORATORIES LTD6.36%
3. ABBOTT INDIA LTD5.63%
4. GLAXOSMITHKLINE PHARMACEUTICALS LTD4.66%
5. CIPLA LTD4.53%
6. DR REDDYS LABORATORIES LTD4.25%
7. PFIZER LTD3.06%
8. MANKIND PHARMA LTD3.02%
9. SYNGENE INTERNATIONAL LTD2.95%
10. SAI LIFE SCIENCES LTD2.89%
11. LUPIN LTD2.64%
12. ALKEM LABORATORIES LTD2.58%
13. PROCTER & GAMBLE HEALTH LTD2.42%
14. FDC LTD2.39%
15. CONCORD BIOTECH LTD1.91%
16. AJANTA PHARMA LTD1.53%
17. NEULAND LABORATORIES LTD1.25%
18. JUBILANT PHARMOVA LTD0.83%
19. BIOCON LTD0.52%
20. ZIM LABORATORIES LTD0.46%
21. SANOFI INDIA LTD0.23%
22. ANTHEM BIOSCIENCES LTD0.01%

1. HEALTHCARE GLOBAL ENTERPRISES LTD5.85%
2. RAINBOW CHILDRENS MEDICARE LTD4.90%
3. MAX HEALTHCARE INSTITUTE LTD4.07%
4. APOLLO HOSPITALS ENTERPRISE LTD3.90%
5. FORTIS HEALTHCARE LTD3.12%
6. DR. LAL PATH LABS LTD2.17%
7. GLOBAL HEALTH LTD2.13%
8. METROPOLIS HEALTHCARE LTD1.12%
9. MANIPAL HEALTH ENTERPRISES LTD0.97%
10. DR. AGARWALS HEALTH CARE LTD0.67%

1. BAYER CROPSCIENCE LTD3.26%
2. SUMITOMO CHEMICAL INDIA LTD1.59%

1. GILLETTE INDIA LTD1.15%
No Data Found
No Data Found

About Fund Tata India Pharma & HealthCare Fund Growth

Tata India Pharma & HealthCare Fund Growth managed by Tata Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹1,541 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.28. Under the expert guidance of Rajat Srivastava ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Rajat Srivastava

Mr. Rajat Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad. Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
ITI Pharma and Healthcare Fund Growth0262 CR2.69
Nippon India Pharma Fund Growth49,279 CR1.85
Tata India Pharma & HealthCare Fund Growth21,541 CR2.28
UTI Healthcare Fund Growth31,370 CR2.22
SBI Healthcare Opportunities Fund Growth35,399 CR2
Fund Name1Y3Y
This FundITI Pharma and Healthcare Fund Growth10.283264.3363
This FundNippon India Pharma Fund Growth9.955864.4973
This FundTata India Pharma & HealthCare Fund Growth8.118467.3398
This FundUTI Healthcare Fund Growth15.248786.542
This FundSBI Healthcare Opportunities Fund Growth18.890887.3539

Tata India Pharma & HealthCare Fund Growth FAQs

Tata India Pharma & HealthCare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Tata India Pharma & HealthCare Fund Growth is 2.28. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Tata India Pharma & HealthCare Fund Growth’s fund performance is as follows:
  • 1 Month : 1.13%
  • 6 Months : 13.48%
  • 1 Year : 8.12%
  • 3 Years : 18.72%
Returns of Tata India Pharma & HealthCare Fund Growth are updated daily based on NAV of ₹ 33.6753 as on Aug 20,2026. Since inception, the return has been 67.34%.

You can invest in Tata India Pharma & HealthCare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Tata India Pharma & HealthCare Fund Growth is ₹1,541 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Tata India Pharma & HealthCare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.